Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccine adjuvants

D W Macy1

  • 1Department of Clinical Sciences, Colorado State University, College of Veterinary Medicine and Biomedical Sciences, Fort Collins 80523, USA.

Seminars in Veterinary Medicine and Surgery (Small Animal)
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feline oncology.

The veterinary quarterly·2011
Same author

Metastatic synovial cell sarcoma in two cats.

Veterinary and comparative oncology·2009
Same author

Current understanding of vaccination site-associated sarcomas in the cat.

Journal of feline medicine and surgery·2002
Same author

Treatment with a combination of doxorubicin, surgery, and radiation versus surgery and radiation alone for cats with vaccine-associated sarcomas: 25 cases (1995-2000).

Journal of the American Veterinary Medical Association·2001
Same author

Review of treatment options for vaccine-associated feline sarcoma.

Journal of the American Veterinary Medical Association·1998
Same author

The potential role of inflammation in the development of postvaccinal sarcomas in cats.

The Veterinary clinics of North America. Small animal practice·1996
Same journal

Diagnosis and treatment of gastrinoma.

Seminars in veterinary medicine and surgery (small animal)·2000
Same journal

Transplantation for the treatment of diabetes mellitus.

Seminars in veterinary medicine and surgery (small animal)·2000
Same journal

Complications and concurrent disease associated with diabetes mellitus.

Seminars in veterinary medicine and surgery (small animal)·2000
Same journal

Oral hypoglycemic agents for noninsulin-dependent diabetes mellitus in the cat.

Seminars in veterinary medicine and surgery (small animal)·2000
Same journal

Management of the uncomplicated canine diabetic.

Seminars in veterinary medicine and surgery (small animal)·2000
Same journal

Diabetic ketoacidosis.

Seminars in veterinary medicine and surgery (small animal)·2000
See all related articles

Veterinary vaccines use diverse adjuvants to boost immune responses. While effective, these vaccine adjuvants can cause adverse side effects, prompting a review of their use and associated risks.

Area of Science:

  • Veterinary immunology
  • Vaccinology
  • Immunotoxicology

Background:

  • Vaccine adjuvants are crucial for enhancing immune responses in veterinary medicine.
  • Unlike human vaccines, veterinary vaccines utilize a broader spectrum of adjuvant substances, often in combination.
  • Adjuvants improve vaccine immunogenicity but are linked to adverse events.

Purpose of the Study:

  • To explore the scientific rationale behind the use of various vaccine adjuvants in veterinary medicine.
  • To review and discuss the adverse events associated with current veterinary vaccine adjuvants.
  • To provide a comprehensive overview of adjuvant utility and safety in veterinary vaccines.

Main Methods:

  • Literature review of scientific publications on veterinary vaccine adjuvants.

Related Experiment Videos

  • Analysis of adjuvant composition and function in commercially available veterinary vaccines.
  • Compilation and categorization of reported adverse events linked to veterinary adjuvants.
  • Main Results:

    • Veterinary vaccines employ a wide array of adjuvants beyond aluminum salts, including oils, saponins, and microbial derivatives.
    • Adjuvants significantly increase the efficacy of veterinary vaccines against various pathogens.
    • A range of adverse events, from local reactions to systemic effects, have been associated with veterinary adjuvants.

    Conclusions:

    • The diverse range of adjuvants in veterinary vaccines offers flexibility in vaccine design but necessitates careful consideration of safety profiles.
    • Understanding the rationale and potential adverse events of vaccine adjuvants is critical for improving veterinary vaccine safety and efficacy.
    • Further research into novel, safer adjuvant formulations is warranted for veterinary applications.